Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jennifer Wischhusen"'
Autor:
David Kryza, Jennifer Wischhusen, Mathieu Richaud, Maëva Hervieu, Jacqueline Sidi Boumedine, Jean‐Guy Delcros, Sophie Besse, Thomas Baudier, Pierre‐Alexandre Laval, Silvia Breusa, Erwan Boutault, Hugo Clermidy, Nicolas Rama, Benjamin Ducarouge, Mojgan Devouassoux‐Shisheboran, Jean‐Michel Chezal, Anne‐Laure Giraudet, Thomas Walter, Patrick Mehlen, David Sarrut, Benjamin Gibert
Publikováno v:
EMBO Molecular Medicine, Vol 15, Iss 4, Pp n/a-n/a (2023)
Abstract Targeted radionuclide therapy is a revolutionary tool for the treatment of highly spread metastatic cancers. Most current approaches rely on the use of vectors to deliver radionuclides to tumor cells, targeting membrane‐bound cancer‐spec
Externí odkaz:
https://doaj.org/article/d9f5252ceab344fca27e6ed88f83c690
Autor:
David Kryza, Jennifer Wischhusen, Mathieu Richaud, Maëva Hervieu, Jacqueline Sidi Boumedine, Jean‐Guy Delcros, Sophie Besse, Thomas Baudier, Pierre‐Alexandre Laval, Silvia Breusa, Erwan Boutault, Hugo Clermidy, Nicolas Rama, Benjamin Ducarouge, Mojgan Devouassoux‐Shisheboran, Jean‐Michel Chezal, Anne‐Laure Giraudet, Thomas Walter, Patrick Mehlen, David Sarrut, Benjamin Gibert
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, 2023, 15, ⟨10.15252/emmm.202216732⟩
EMBO Molecular Medicine, 2023, 15, ⟨10.15252/emmm.202216732⟩
International audience; Targeted radionuclide therapy is a revolutionary tool for the treatment of highly spread metastatic cancers. Most current approaches rely on the use of vectors to deliver radionuclides to tumor cells, targeting membrane-bound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a9bcbf1f2752c2a6e92c99edabd903c
https://cnrs.hal.science/hal-04107206
https://cnrs.hal.science/hal-04107206
Autor:
F. Padilla, Jennifer Wischhusen
Publikováno v:
Innovation and Research in BioMedical engineering
Innovation and Research in BioMedical engineering, Elsevier Masson, 2019, 40, pp.10-15. ⟨10.1016/j.irbm.2018.11.005⟩
Innovation and Research in BioMedical engineering, Elsevier Masson, 2019, 40, pp.10-15. ⟨10.1016/j.irbm.2018.11.005⟩
Background Ultrasound-targeted microbubble destruction (UTMD) is a type of ultrasound therapy, in which low frequency moderate power ultrasound is combined with microbubbles to trigger cavitation. Cavitation is the process of oscillation of gas bubbl
Autor:
Ramasamy Paulmurugan, Rammohan Devulapally, Uday Kumar Sukumar, Sunitha V. Bachawal, Huaijun Wang, Rayhaneh Afjei, Sayan Mullick Chowdhury, Taehwa Lee, Jennifer Wischhusen
Publikováno v:
J Control Release
Hepatocellular carcinoma (HCC) is the most common cause of cancer-related mortality, and patients with HCC show poor response to currently available treatments, which demands new therapies. We recently developed a synthetic microRNA-based molecularly
Publikováno v:
Journal of Visualized Experiments.
Monoclonal antibodies (mAbs) are important tools in cancer detection, diagnosis, and treatment. They are used to unravel the role of proteins in tumorigenesis, can be directed to cancer biomarkers enabling tumor detection and characterization, and ca
Autor:
F. Padilla, Jennifer Wischhusen
Publikováno v:
Innovation and Research in BioMedical engineering
Innovation and Research in BioMedical engineering, Elsevier Masson, 2019, 40, pp.3-9. ⟨10.1016/j.irbm.2018.10.007⟩
Innovation and Research in BioMedical engineering, Elsevier Masson, 2019, 40, pp.3-9. ⟨10.1016/j.irbm.2018.10.007⟩
Background Ultrasound plays an important role in cancer diagnosis. B-mode imaging and contrast-enhanced ultrasound are routinely used to detect cancerous lesions in breast and liver. The use of ultrasound contrast agents (UCAs) such as microbubbles (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9febffdecfd58b583b61c46137486b9
https://hal.archives-ouvertes.fr/hal-03484596/document
https://hal.archives-ouvertes.fr/hal-03484596/document
Autor:
Lu Tian, Sunitha V. Bachawal, Rammohan Devulapally, Ramasamy Paulmurugan, Taehwa Lee, Jennifer Wischhusen, Tristan Alan Yeung, Sayan Mullick Chowdhury, Juergen K. Willmann, Jeremy J. Dahl, Lotfi Abou-Elkacem
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 281
Hepatocellular carcinoma (HCC) is the second-leading cause of cancer related deaths worldwide and new strategies to efficiently treat HCC are critically needed. The aim of this study was to assess the longitudinal treatment effects of two complementa
Autor:
Jennifer Wischhusen, Frederic Padilla
Publikováno v:
Ultrasound in medicinebiology. 43(7)
Targeted microbubbles (MBs) are ultrasound contrast agents that are functionalized with a ligand for ultrasound molecular imaging of endothelial markers. Novel targeted MBs are characterized in vitro by incubation in protein-coated wells, followed by
Autor:
Karim Harhouri, Françoise Dignat-George, Romaric Lacroix, Philippe Poncelet, Jennifer Wischhusen, Laurent Arnaud, Coralie Judicone, Stéphane Robert, Tarik Bouriche
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 32:1054-1058
Objective— Cellular microparticles (MP) are promising biomarkers in many pathological situations. Although flow cytometry (FCM) is widely used for their measurement, it has raised controversies because the smallest MP size falls below the detection
Autor:
Jean-Guy Delcros, Jennifer Wischhusen, Patrick Mehlen, Frederic Padilla, Juergen K. Willmann, Katheryne E. Wilson, Benjamin Gibert, Rodolfo Molina
Publikováno v:
The Journal of the Acoustical Society of America. 142:2563-2563
With regard to biomarker expression, tumors are heterogeneous media displaying intra- and interpatient variability. Ultrasound molecular imaging (USMI) is a newly developed tool that can characterize heterogeneous tumors. Here, we focus on Netrin-1-o